TOP STORIES

• REGULATORY LDP Wins Landslide Victory in Lower House Election; Ex-Lawmakers Return as Centrists Routed
  February 9, 2026

• COMMENTARY Is Calling for an Abolition the Right Play? Rethinking Japan’s FY2027 Off-Year Drug Price Revision
  February 9, 2026

• ORGANIZATION Generic Industry Consolidation Opens Opportunities for CMOs: Industry Chief
  February 6, 2026

• BUSINESS Lilly Discloses Japan Filing for Orforglipron, Starting with Obesity
  February 6, 2026

• BUSINESS Ono Recalls Certain Opdivo Lots over Possible Metal Contamination
  February 6, 2026

• COMMENTARY Japan’s Biological Raw Material Rules Enter Major Revision; Clarity on Benefits and Safety Holds Key
  February 5, 2026

• BUSINESS Trazenta Faces Multiple Patent Challenges Ahead of Anticipated Generic Entry
  February 4, 2026

• BUSINESS Sawai Cedes to Merck in Januvia Row, Accepts Patent Scope
  February 4, 2026

• ORGANIZATION FIRM Warns Conditional Approval Pricing Change Could Chill Regenerative Medicine R&D
  February 3, 2026

• BUSINESS AstraZeneca Names Andy Barnett as New Japan President
  February 3, 2026

• BUSINESS Fuji Says Eylea Biosimilar Patent Risk Cleared under Global Settlement
  February 2, 2026

• BUSINESS Takeda Rejigs Structure Ahead of CEO Transition, Creates New International Unit
  January 30, 2026

• REGULATORY Japan Panel Green-Lights Pfizer’s Tukysa, Wider Labels for Tezspire, and More Drugs
  January 30, 2026

• REGULATORY Entyvio, Rexulti, and Lenvima among 15 More Drugs Picked for IRA Price Talks
  January 29, 2026

• REGULATORY Japan’s Lower House Campaign Begins amid Fragmented Political Set-Up
  January 28, 2026

• REGULATORY Former LDP Lawmakers Outline Drug Policy Priorities in Comeback Bids
  January 28, 2026

• BUSINESS Ajinomoto Builds Presence in ADC CDMO Business with Proprietary Technology
  January 27, 2026

• REGULATORY Japan Panel OKs AbbVie’s Aquipta, Ipsen’s Sohonos, and Novo’s IcoSema for Approval
  January 26, 2026

• BUSINESS Will Unlisted AGs Rush for June Listing or Be Left on Ice?
  January 23, 2026

• REGULATORY Japan’s 1st Xolair Biosimilar Likely from Celltrion as JAN Is Assigned
  January 23, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »